1. Home
  2. HEQ vs OVID Comparison

HEQ vs OVID Comparison

Compare HEQ & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Hedged Equity & Income Fund of Beneficial Interest

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$10.78

Market Cap

133.9M

Sector

Finance

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEQ
OVID
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.9M
116.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
HEQ
OVID
Price
$10.78
$1.79
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.50
AVG Volume (30 Days)
43.1K
1.9M
Earning Date
01-01-0001
11-12-2025
Dividend Yield
9.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,610,000.00
Revenue This Year
N/A
$1,077.56
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
945.89
52 Week Low
$9.08
$0.24
52 Week High
$11.84
$2.01

Technical Indicators

Market Signals
Indicator
HEQ
OVID
Relative Strength Index (RSI) 48.45 60.01
Support Level $10.70 $1.26
Resistance Level $10.82 $1.64
Average True Range (ATR) 0.10 0.13
MACD -0.02 0.02
Stochastic Oscillator 25.01 83.87

Price Performance

Historical Comparison
HEQ
OVID

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: